HomeHealth

Health

Kintara Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement

Kintara Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement

June 3, 2022

Akebia Therapeutics to Present at Jefferies Healthcare Conference

Akebia Therapeutics to Present at Jefferies Healthcare Conference

June 3, 2022

US Food and Drug Administration Extends Phexxi® Shelf Life to Four Years

US Food and Drug Administration Extends Phexxi® Shelf Life to Four Years

June 2, 2022

Emergent BioSolutions to Participate in Investor Conferences

Emergent BioSolutions to Participate in Investor Conferences

June 2, 2022

Hillstream BioPharma Provides Corporate Update

Hillstream BioPharma Provides Corporate Update

June 2, 2022

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 2, 2022

Cosmos Holdings to Launch Sky Premium Life Nutritional Supplements on Amazon in the United States

Cosmos Holdings to Launch Sky Premium Life Nutritional Supplements on Amazon in the United States

June 2, 2022

Guardion Health Sciences Announces Agreement with OmegaQuant Laboratories

Guardion Health Sciences Announces Agreement with OmegaQuant Laboratories

June 1, 2022

Compugen to Present at Upcoming Investor Conferences

Compugen to Present at Upcoming Investor Conferences

June 1, 2022

Outlook Therapeutics Provides Update on Biologics License Application (BLA) Submission for ONS-5010 as a Treatment for Wet AMD

Outlook Therapeutics Provides Update on Biologics License Application (BLA) Submission for ONS-5010 as a Treatment for Wet AMD

May 31, 2022

« 1 … 120 121 122 123 »